Eleuthero Root
Eleuthero root (Eleutherococcus senticosus) is an adaptogen formerly marketed as 'Siberian ginseng' — but it is NOT a true ginseng (it's a different genus from Panax). Real but modest RCT evidence for endurance performance, recurrent herpes outbreaks, and quality of life in elderly patients. Chronic-fatigue trials have been negative overall. Don't expect Panax-ginseng-like effects from eleuthero.
Quick decision guide
May help most
Adults exploring an adjunct for general fatigue, recurrent HSV-2 outbreaks (one of the few specific clinical wins), or endurance performance under monitoring.
Common dosing range
300–1,200 mg/d standardized eleuthero root extract (0.8% eleutherosides B+E), in divided doses.
When to expect effects
4–8 weeks for performance and quality-of-life effects; longer for immune/herpes use.
Watch out for
Don't conflate with Panax ginseng — different species, different evidence. Avoid in uncontrolled hypertension and during pregnancy.
Evidence snapshot
What is it
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
Endurance / aerobic performance Limited Evidence | ~12% VO2 peak increase and longer time-to-exhaustion over 8 weeks in 9-subject crossover; consistent direction across older Soviet literature | Recreational and amateur endurance athletes willing to do an 8-week trial | 8 weeks |
Recurrent herpes simplex (HSV-2) outbreaks Limited Evidence | Reduced frequency, severity, and duration of HSV-2 outbreaks at 2 g/d over 6 months | Adults with recurrent HSV-2 outbreaks who want a daily adjunct alongside conventional management | Weeks to months (6-month trial) |
Quality of life in elderly Limited Evidence | Improved SF-36 mental health and social-function scores at 300 mg/d for 8 weeks | Older adults with stable BP exploring a gentle QOL adjunct under clinician guidance | 8 weeks |
Immune cell counts (mechanism / biomarker) Limited Evidence | Significant rise in T-lymphocyte subsets and NK cell activity at 4 weeks | Research context — supports immune-modulation hypothesis | 4 weeks |
Chronic fatigue syndrome (CFS) Mixed Evidence | Null overall in 96-patient CFS RCT; subgroup signals not confirmatory | Possibly people with milder, shorter-duration fatigue (subgroup hint only) | 2 months tested |
Endurance / aerobic performance
- Effect
- ~12% VO2 peak increase and longer time-to-exhaustion over 8 weeks in 9-subject crossover; consistent direction across older Soviet literature
- Best fit
- Recreational and amateur endurance athletes willing to do an 8-week trial
- Time
- 8 weeks
Recurrent herpes simplex (HSV-2) outbreaks
- Effect
- Reduced frequency, severity, and duration of HSV-2 outbreaks at 2 g/d over 6 months
- Best fit
- Adults with recurrent HSV-2 outbreaks who want a daily adjunct alongside conventional management
- Time
- Weeks to months (6-month trial)
Quality of life in elderly
- Effect
- Improved SF-36 mental health and social-function scores at 300 mg/d for 8 weeks
- Best fit
- Older adults with stable BP exploring a gentle QOL adjunct under clinician guidance
- Time
- 8 weeks
Immune cell counts (mechanism / biomarker)
- Effect
- Significant rise in T-lymphocyte subsets and NK cell activity at 4 weeks
- Best fit
- Research context — supports immune-modulation hypothesis
- Time
- 4 weeks
Chronic fatigue syndrome (CFS)
- Effect
- Null overall in 96-patient CFS RCT; subgroup signals not confirmatory
- Best fit
- Possibly people with milder, shorter-duration fatigue (subgroup hint only)
- Time
- 2 months tested
Evidence for 5 uses
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
Endurance / aerobic performance
Supplement benefitKuo 2010 ran a double-blind crossover in 9 recreational male cyclists on 800 mg/d eleuthero for 8 weeks. Significant gains: +12% VO2 peak, increased maximal heart rate, longer time to exhaustion vs placebo. Small sample but the crossover design controls for individual variability. Earlier Soviet-era literature consistently reported endurance and stamina benefits, though methodological rigor was variable. The modern signal is real but small; treat as an adjunct, not a primary performance intervention.
Bottom line: Modest performance signal; worth trying for 8 weeks if you're curious. Don't substitute for actual training.
Recurrent herpes simplex (HSV-2) outbreaks
Disease adjunctWilliams 1995 ran a double-blind placebo-controlled trial in 93 patients with recurrent HSV-2 infections — eleuthero 2 g/d for 6 months reduced the frequency, severity, and duration of outbreaks vs placebo. This is one of the few specific clinical outcomes with positive RCT support for eleuthero, but the trial hasn't been independently replicated at large scale. Use as an adjunct alongside (not replacing) prescription antivirals if your outbreak pattern warrants suppressive therapy.
Bottom line: Real positive RCT; not a replacement for prescription antivirals.
Quality of life in elderly
Supplement benefitCicero 2004 placebo-controlled trial in 20 elderly hypertensive patients on 300 mg/d for 8 weeks — significant improvement in mental health, social functioning, and quality-of-life scores (SF-36) vs placebo. No adverse BP effects in this small trial. Sample size is small; broader replication is lacking. Reasonable as a gentle adjunct in older adults with stable BP.
Bottom line: Small but real signal in a specific population; talk to your clinician given the medication-interaction landscape in older adults.
Immune cell counts (mechanism / biomarker)
Biomarker supportBohn 1987 randomized 36 healthy volunteers to eleuthero or placebo for 4 weeks — treatment significantly increased absolute T-lymphocyte counts (helper, suppressor, cytotoxic) and NK cell activity. This is biomarker evidence: rising immune cell counts in healthy people doesn't automatically translate to fewer infections or better clinical outcomes. Useful as mechanism context for the herpes-outbreak finding.
Bottom line: Real immune-cell biomarker effect; clinical translation is harder.
Chronic fatigue syndrome (CFS)
Supplement benefitHartz 2004's RCT in 96 CFS patients on eleuthero 750–1,000 mg/d for 2 months was negative overall — no significant difference vs placebo in fatigue measures. Subgroup signals suggested possible benefit in patients with shorter-duration, less-severe fatigue, but the primary result was null. Don't expect eleuthero to treat CFS.
Bottom line: Don't take eleuthero specifically for CFS — the best trial was negative.
How it works
How to take it
What to track
Bottom line: Start at 300–800 mg/d standardized extract, in morning and midday doses. Try for 8 weeks. Stop if no clear benefit or if BP / sleep deteriorate.
4 commercial forms
Compare the main delivery options and what they’re best suited for.
Standardized eleuthero root extract (0.8% eleutherosides B+E)
Most reliableThe form used in most modern RCTs. 100–400 mg per capsule, taken 2–3 times/day to hit 300–1,200 mg/d. The standardization to eleutherosides B+E is the key — without it, potency is unpredictable.
Variable per batch even when standardized; eleutheroside content is the best practical marker.
Eleuthero root liquid extract / tincture
TraditionalAlcohol or glycerin extract of eleuthero root. Traditional Russian and Eastern European format. Potency varies dramatically by extraction ratio (1:1 to 1:5) and by source root quality.
Hard to compare to standardized extract products; dose by drops per label.
Crude eleuthero root powder / tea
Whole herbDried root, powdered or sliced for tea. Lowest cost; least reliable for clinical-effect dosing because eleutheroside content isn't standardized.
Unpredictable eleutheroside delivery; typical use is 2–3 g/d as tea.
'Siberian ginseng' (legacy/marketing name)
Misleading labelSame plant as eleuthero — NOT a true ginseng. The FDA prohibited 'ginseng' on Eleutherococcus product labels in 2002 in the US to prevent confusion with Panax ginseng. International labels may still use the legacy name. Read the Latin name: Eleutherococcus senticosus, not Panax.
Same as eleuthero — just the wrong name.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Quality control issues: adulteration with Periploca sepium (Chinese silkvine, NOT eleuthero) has been documented. The substitution caused at least one well-known case report of digoxin level elevation that was originally attributed to eleuthero.
Possible elevation of serum digoxin in case reports — likely from adulteration with Periploca, but eleuthero itself may also interact. Avoid combination or monitor digoxin levels carefully.
May raise blood pressure in some users, especially with pre-existing hypertension. Older Soviet labeling listed uncontrolled hypertension as a contraindication.
Immune-stimulating effect may interfere with immunosuppressive therapy (post-transplant, autoimmune disease, biologics). Avoid in these settings.
Who should avoid it
- Pregnant or breastfeeding women — uterine effects reported in animal studies; limited human safety data.
- People with uncontrolled hypertension or unstable cardiovascular disease.
- People on digoxin — case reports of dangerously elevated digoxin levels.
- People on immunosuppressants (cyclosporine, tacrolimus, biologics) or post-organ-transplant.
- People with autoimmune disease — theoretical concern with immune stimulation.
- People on warfarin, DOACs, or other anticoagulants — possible additive bleeding risk.
Pregnancy & breastfeeding
Avoid in pregnancy and breastfeeding. Animal studies show uterine effects; human safety data is limited. Eleuthero is not worth the unknowns when pregnant or trying to conceive. The MSKCC monograph explicitly contraindicates eleuthero in pregnancy.
Bottom line: More interaction-prone than most adaptogens. The digoxin and immunosuppressant interactions are the ones to memorize.
Interactions
Case reports of dangerously elevated serum digoxin during eleuthero use (some now thought to involve Periploca adulteration; eleuthero itself may also interact). Avoid combination or monitor digoxin levels closely.
Eleuthero's immune-stimulating effect may counter the intended immune suppression and worsen autoimmune disease or risk transplant rejection. Avoid.
Theoretical and limited case-report evidence of altered anticoagulation. Monitor INR closely if you start eleuthero while on warfarin; flag any new bleeding.
Eleuthero can raise BP in some users, potentially reducing antihypertensive effect. Monitor BP after starting.
Eleuthero may reduce the sedative effect of barbiturates and similar drugs (older Russian literature). Clinical relevance uncertain in modern practice.
Eleuthero may have mild blood-glucose-lowering effects; monitor glucose if you start it while on diabetes medications.
Choosing a product
What to look for on the label — and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Is eleuthero ginseng?⌄
No. The name Siberian ginseng is marketing; eleuthero is in the same family but a different genus.
References by claim
Chronic fatigue syndrome (CFS)
Hartz et al., 2004 — PubMed — Psychological Medicine (2004) link
Endurance / aerobic performance
Kuo et al., 2010 — PubMed — Chinese Journal of Physiology (2010) link
Quality of life in elderly
Cicero et al., 2004 — PubMed — Archives of Gerontology and Geriatrics (2004) link
Immune cell counts (mechanism / biomarker)
Bohn et al., 1987 — PubMed — Arzneimittelforschung (1987) link
Recurrent herpes simplex (HSV-2) outbreaks
Williams, 1995 — PubMed — Journal of the American Pharmaceutical Association (1995) link
Safety
Memorial Sloan Kettering — About Herbs — Eleuthero (Eleutherococcus senticosus) monograph (2024) link
Track Eleuthero Root with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.